Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene

Chemico-Biological Interactions

Volumn 135, Issue 136, 2001, Pages 599-614

  Bond, James A ^a   Medinsky, Michele A ^a  

^a ToxCon   (United States)

Author keywords

Butadiene; Carcinogensis; Toxicodynamics; Toxicokinetics

Indexed keywords

1,3 BUTADIENE; BIOLOGICAL MARKER; BUTADIENE DIEPOXIDE; CYTOCHROME P450; CYTOCHROME P450 2E1; ISOENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CONFERENCE PAPER; CONTROLLED STUDY; DETOXIFICATION; DOSIMETRY; HUMAN; HUMAN TISSUE; INHALATION; LEUKEMIA; METABOLIC ACTIVATION; MOUSE; MUTAGENICITY; NONHUMAN; POINT MUTATION; RAT; RISK ASSESSMENT; RISK FACTOR; RUBBER INDUSTRY; SPECIES DIFFERENTIATION; TOXICOKINETICS;

ANIMALS; BIOTRANSFORMATION; BUTADIENES; CARCINOGENS; HUMANS; METABOLIC DETOXICATION, DRUG; MICE; MUTAGENICITY TESTS; MUTAGENS; RATS; SPECIES SPECIFICITY;

RODENTIA;

EID: 0035369266     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(01)00199-5     Document Type: Article

References (36)

1. Analysis of 1,3-butadiene and other gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection
2. Analysis of low molecular weight hydrocarbons including 1,3-butadiene as engine exhaust gases using an aluminum oxide porous-layer open-tubular fused-silica column
3. Preliminary draft list of categories and subcategories under Section 112 of the Clean Air Act
4. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure
5. Carcinogenicity of 1,3-butadiene in B6C3F1 mice at low exposure concentrations
6. Inhalation toxicity studies with 1,3-butadiene. III. Two-year toxicity/carcinogenicity studies in rats
7. A follow-up study of butadiene production workers
8. Toxicology and epidemiology of 1,3-butadiene
9. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice
10. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse, and rat liver microsomes
11. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation
12. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene
13. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene
14. Biological monitoring of butadiene exposure by measurement of haemoglobin adducts
15. Quantitative and qualitative differences in the metabolism of 14C-1,3-butadiene in rats and mice: Relevance to cancer susceptibility
16. The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro
17. Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and mouse liver and lung in vitro
18. Toxicokinetics: Biotransformation of toxicants
19. Metabolism of butadiene by mice, rats, and humans: A comparison of physiologically based toxicokinetic model predictions and experimental data
20. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene
21. Analysis of butadiene, butadiene monoxide, and butadiene dioxide in blood by gas chromatography/gas chromatography/mass spectroscopy
22. Characterization of hprt mutations following 1,2-epoxy-3-butene exposure of human TK6 cells
23. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity
24. Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2:3,4-diepoxybutane
25. Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes
26. Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2:3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts
27. In vitro and in vivo mutagenicity of the butadiene metabolites butadiene diolepoxide, butadiene monoepoxide and diepoxybutane
28. Clastogenicity of diepoxybutane in bone marrow cells and germ cells of mice
29. Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment
30. Species differences in urinary butadiene metabolites: Comparisons of metabolite ratios between mice, rats, and humans
31. N7-(1-(Hydroxymethyl)-2,3-dihydroxypropyl) guanine is the major DNA adduct after exposure to 1,3-butadiene but not 1,2-epoxy-3-butene
32. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochromes P450 2A6 and 2E1
33. Inhibition of cytochrome P450 2E1, decreases but does not eliminate, genotoxicity mediated by 1,3-butadiene
34. The use of cytochrome P450 2E1 knockout mice to develop a mechanistic understanding of carcinogen biotransformation and toxicity
35. In vivo metabolism of butadiene by mice and rats: A comparison of physiological model predictions and experimental data
36. Cellular and molecular basis for species, sex and tissue differences in 1,3-butadiene metabolism